In8Bio (INAB) Non-Current Assets (2020 - 2026)
In8Bio (INAB) recorded Non-Current Assets of $3.25 million in Q2 2026, down 42.3% from $5.63 million a year earlier and down 9.8% from the prior quarter.
Powered by 
Analysis
In8Bio (INAB) Non-Current Assets (2020 - 2026) Analysis & Trends
At the end of FY2025, In8Bio reported Non-Current Assets of $4.4 million, down 47.4% from FY2024.
- Annual Non-Current Assets has declined for three straight years, though with a five-year compound annual growth rate of 9.7% (FY2020 to FY2025).
- Across earlier years, Non-Current Assets came in at $8.37 million in FY2024 (-7.9%), $9.08 million in FY2023 (-15.9%), $10.81 million in FY2022 (+233.2%) and $3.24 million in FY2021 (+17.2%).
- The Q2 2026 figure is the lowest quarterly Non-Current Assets since Q4 2021.
- On a year-over-year basis, Non-Current Assets has declined for five consecutive quarters, with an average decline of 34.3% over the last seven quarters.
- Peak year-over-year performance for Non-Current Assets in the last five years was growth of 233.2% in Q4 2022, against a decline of 49.6% in Q1 2026 at the low end.
- Per Business Quant, the preceding three quarters came in at $3.6 million (Q1 2026), $4.4 million (Q4 2025) and $5 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 141.29 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | 101.45 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 125.00 Mn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | 94.68 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | 87.87 Bn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 60.68 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 35.42 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | 159.77 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 14.88 Bn |
| 10 | In8Bio | 25.89 Mn | 25.89 Mn | - | 3.25 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 3.25 Mn |
| Mar 31, 2026 | 3.60 Mn |
| Dec 31, 2025 | 4.40 Mn |
| Sep 30, 2025 | 5.00 Mn |
| Jun 30, 2025 | 5.63 Mn |
| Mar 31, 2025 | 7.14 Mn |
| Dec 31, 2024 | 8.37 Mn |
| Sep 30, 2024 | 9.26 Mn |
| Jun 30, 2024 | 9.81 Mn |
| Dec 31, 2023 | 9.08 Mn |
| Sep 30, 2023 | 9.66 Mn |
| Jun 30, 2023 | 10.25 Mn |
| Mar 31, 2023 | 10.28 Mn |
| Dec 31, 2022 | 10.81 Mn |
| Sep 30, 2022 | 8.73 Mn |
| Jun 30, 2022 | 3.99 Mn |
| Mar 31, 2022 | 3.26 Mn |
| Dec 31, 2021 | 3.24 Mn |
| Sep 30, 2021 | 3.26 Mn |
| Jun 30, 2021 | 5.40 Mn |
API Access
In8Bio Non-Current Assets API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=non-current-assets&ticker=INAB&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "non-current-assets", "ticker": "INAB", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=non-current-assets&ticker=INAB&period=max&api_key=YOUR_API_KEY");
const data = await res.json();